Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
April 07 2021 - 7:30AM
Conformis, Inc. (NASDAQ: CFMS) announced today that it will release
its financial results for the first quarter ended March 31, 2021
after the market closes on May 5, 2021 at approximately 4:00 p.m.
Eastern Time.
Mark Augusti, CEO, and Bob Howe, CFO, will host
a webcast and conference call also on Wednesday, May 5, 2021, at
4:30 p.m. Eastern Time to discuss the financial results and to
provide a business update.
The webcast will be live at:
https://edge.media-server.com/mmc/p/vnzdh2h9.
To attend by telephone, please use the
information below for dial-in access.
- When prompted on
dial-in, please utilize conference ID: 8727027.
- Participant
conference numbers (877) 809-6331 (U.S./Canada) and (615) 247-0224
(International).
- Please dial in
at least 10 minutes before the call to ensure timely
participation.
Please visit the Investor Relations website at
ir.conformis.com on May 5, 2021 to view the earnings release prior
to the webcast and conference call.
The online archive of the webcast will be
available on the company’s website at ir.conformis.com for 30
days.
About Conformis, Inc.
Conformis is a medical technology company that
uses its proprietary iFit Image-to-Implant technology platform to
develop, manufacture, and sell joint replacement implants and
instruments that are individually sized and shaped, which we refer
to as personalized, individualized, or sometimes as customized, to
fit each patient's unique anatomy. Conformis offers a broad
line of sterile, personalized knee and hip implants and single-use
instruments delivered to hospitals and ambulatory surgical
centers. In clinical studies, the Conformis iTotal CR knee
replacement system demonstrated superior clinical outcomes,
including better function and greater patient satisfaction,
compared to traditional, off-the-shelf implants. Conformis owns or
exclusively in-licenses issued patents and pending patent
applications that cover personalized implants and patient-specific
instrumentation for all major joints.
For more information, visit www.conformis.com.
To receive future releases in e-mail alerts, sign up at
http://ir.conformis.com/.
Contact
Investor Contact:
Investor Relations
ir@conformis.com
(781) 374-5598
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Conformis (NASDAQ:CFMS)
Historical Stock Chart
From Apr 2023 to Apr 2024